Kolmar BNH Co., Ltd.

KOSDAQ 200130.KQ

Kolmar BNH Co., Ltd. EPS (Diluted) for the year ending December 31, 2023: USD 0.52

Kolmar BNH Co., Ltd. EPS (Diluted) is USD 0.52 for the year ending December 31, 2023, a -52.19% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Kolmar BNH Co., Ltd. EPS (Diluted) for the year ending December 31, 2022 was USD 1.08, a -45.27% change year over year.
Kolmar BNH Co., Ltd. EPS (Diluted) for the year ending December 31, 2021 was USD 1.98, a -20.85% change year over year.
Kolmar BNH Co., Ltd. EPS (Diluted) for the year ending December 31, 2020 was USD 2.50, a 57.32% change year over year.
Kolmar BNH Co., Ltd. EPS (Diluted) for the year ending December 31, 2019 was USD 1.59, a 8.65% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

KOSDAQ: 200130.KQ

Kolmar BNH Co., Ltd.

CEO	Mr. Hwa-Yeong Jung
IPO Date	Jan. 16, 2015
Location	South Korea
Headquarters	22-15, Sandan-gil
Employees	512
Sector	Consumer Discretionary
Industries Cosmetics Biotechnology Pharmaceuticals

Description

Kolmar BNH Co., Ltd. engages in the research and development of cosmetics, health functional foods, and functional ingredients in South Korea and internationally. It also provides vitamins and minerals, weight control, sports/nutrition, intestinal health, and other products, as well as products for men/women. The company was formerly known as Sun Bio Tech and changed its name to Kolmar BNH Co., Ltd. in 2013. The company was founded in 2004 and is based in Sejong, South Korea. Kolmar BNH Co., Ltd. is a subsidiary of Kolmar Korea Holdings Co., Ltd.

Key trends

Past 5 years